Narcotic and benzodiazepine use after withdrawal of life support: Association with time to death?
To determine whether the dose of narcotics and benzodiazepines is associated with length of time from mechanical ventilation withdrawal to death in the setting of withdrawal of life-sustaining treatment in the ICU. Retrospective chart review. University-affiliated, level I trauma center. Consecutive...
Gespeichert in:
Veröffentlicht in: | Chest 2004-07, Vol.126 (1), p.286-293 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 293 |
---|---|
container_issue | 1 |
container_start_page | 286 |
container_title | Chest |
container_volume | 126 |
creator | CHAN, Jeannie D TREECE, Patsy D ENGELBERG, Ruth A CROWLEY, Lauren RUBENFELD, Gordon D STEINBERG, Kenneth P CURTIS, J. Randall |
description | To determine whether the dose of narcotics and benzodiazepines is associated with length of time from mechanical ventilation withdrawal to death in the setting of withdrawal of life-sustaining treatment in the ICU.
Retrospective chart review.
University-affiliated, level I trauma center.
Consecutive critically ill patients who had mechanical ventilation withdrawn and subsequently died in the ICU during two study time periods.
There were 75 eligible patients with a mean age of 59 years. The primary ICU admission diagnoses included intracranial hemorrhage (37%), trauma (27%), acute respiratory failure (27%), and acute renal failure (20%). Patients died during a median of 35 min (range, 1 to 890 min) after ventilator withdrawal. On average, 16.2 mg/h opiates in morphine equivalents and 7.5 mg/h benzodiazepine in lorazepam equivalents were administered during the time period starting 1 h before ventilator withdrawal and ending at death. There was no statistically significant relationship between the average hourly narcotic and benzodiazepine use during the 1-h period prior to ventilator withdrawal until death, and the time from ventilator withdrawal to death. The restriction of medication assessment in the last 2 h of life showed an inverse association between the use of benzodiazepines and time to death. For every 1 mg/h increase in benzodiazepine use, time to death was increased by 13 min (p = 0.015). There was no relationship between narcotic dose and time to death during the last 2 h of life (p = 0.11).
We found no evidence that the use of narcotics or benzodiazepines to treat discomfort after the withdrawal of life support hastens death in critically ill patients at our center. Clinicians should strive to control patient symptoms in this setting and should document the rationale for escalating drug doses. |
doi_str_mv | 10.1016/S0012-3692(15)32925-1 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_66701252</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66701252</sourcerecordid><originalsourceid>FETCH-LOGICAL-p196t-9bd7d36832912b73c9ac8648a1dbfab3dddf590714c494b4c7571317d91523b43</originalsourceid><addsrcrecordid>eNpd0E1LxDAQBuAgiq6rP0EJgqKHar7abryILH6B6EE9l2mSYqRtapKyuL_eoKuIp2HgYXjnRWiPklNKaHH2RAhlGS8kO6b5CWeS5RldQxMqOc14Lvg6mvySLbQdwhtJO5XFJtqiORNSlHyC4AG8ctEqDL3GtemXTltYmsH2Bo_BYGii8Xhh46v2sIAWuwa3tjE4jMPgfDzHlyE4ZSFa1385HG1ncHRYG4ivFztoo4E2mN3VnKKX66vn-W12_3hzN7-8z4aUKWay1qXmxSx9QlldciVBzQoxA6rrBmqutW5ySUoqVIpeC1XmJeW01DI9w2vBp-jo--7g3ftoQqw6G5RpW-iNG0NVFGWqI9kpOvgH39zo-5StYoQIRlhOE9pfobHujK4GbzvwH9VPcwkcrgAEBW3joVc2_HEyFzNG-CceiX1R</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>200420251</pqid></control><display><type>article</type><title>Narcotic and benzodiazepine use after withdrawal of life support: Association with time to death?</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>CHAN, Jeannie D ; TREECE, Patsy D ; ENGELBERG, Ruth A ; CROWLEY, Lauren ; RUBENFELD, Gordon D ; STEINBERG, Kenneth P ; CURTIS, J. Randall</creator><creatorcontrib>CHAN, Jeannie D ; TREECE, Patsy D ; ENGELBERG, Ruth A ; CROWLEY, Lauren ; RUBENFELD, Gordon D ; STEINBERG, Kenneth P ; CURTIS, J. Randall</creatorcontrib><description>To determine whether the dose of narcotics and benzodiazepines is associated with length of time from mechanical ventilation withdrawal to death in the setting of withdrawal of life-sustaining treatment in the ICU.
Retrospective chart review.
University-affiliated, level I trauma center.
Consecutive critically ill patients who had mechanical ventilation withdrawn and subsequently died in the ICU during two study time periods.
There were 75 eligible patients with a mean age of 59 years. The primary ICU admission diagnoses included intracranial hemorrhage (37%), trauma (27%), acute respiratory failure (27%), and acute renal failure (20%). Patients died during a median of 35 min (range, 1 to 890 min) after ventilator withdrawal. On average, 16.2 mg/h opiates in morphine equivalents and 7.5 mg/h benzodiazepine in lorazepam equivalents were administered during the time period starting 1 h before ventilator withdrawal and ending at death. There was no statistically significant relationship between the average hourly narcotic and benzodiazepine use during the 1-h period prior to ventilator withdrawal until death, and the time from ventilator withdrawal to death. The restriction of medication assessment in the last 2 h of life showed an inverse association between the use of benzodiazepines and time to death. For every 1 mg/h increase in benzodiazepine use, time to death was increased by 13 min (p = 0.015). There was no relationship between narcotic dose and time to death during the last 2 h of life (p = 0.11).
We found no evidence that the use of narcotics or benzodiazepines to treat discomfort after the withdrawal of life support hastens death in critically ill patients at our center. Clinicians should strive to control patient symptoms in this setting and should document the rationale for escalating drug doses.</description><identifier>ISSN: 0012-3692</identifier><identifier>EISSN: 1931-3543</identifier><identifier>DOI: 10.1016/S0012-3692(15)32925-1</identifier><identifier>PMID: 15249473</identifier><identifier>CODEN: CHETBF</identifier><language>eng</language><publisher>Northbrook, IL: American College of Chest Physicians</publisher><subject>Adolescent ; Adult ; Aged ; Anesthesia ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; APACHE ; Benzodiazepines ; Benzodiazepines - administration & dosage ; Biological and medical sciences ; Cardiology. Vascular system ; Critical care ; Ethics, Medical ; Euthanasia, Passive - ethics ; Female ; Fentanyl ; Glasgow Coma Scale ; Humans ; Intensive Care Units ; Male ; Medical sciences ; Middle Aged ; Morphine ; Narcotics ; Narcotics - administration & dosage ; Nurses ; Palliative care ; Physicians ; Pneumology ; Quality improvement ; Respiration, Artificial ; Retrospective Studies ; Time Factors ; Ventilators</subject><ispartof>Chest, 2004-07, Vol.126 (1), p.286-293</ispartof><rights>2004 INIST-CNRS</rights><rights>Copyright American College of Chest Physicians Jul 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15954820$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15249473$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>CHAN, Jeannie D</creatorcontrib><creatorcontrib>TREECE, Patsy D</creatorcontrib><creatorcontrib>ENGELBERG, Ruth A</creatorcontrib><creatorcontrib>CROWLEY, Lauren</creatorcontrib><creatorcontrib>RUBENFELD, Gordon D</creatorcontrib><creatorcontrib>STEINBERG, Kenneth P</creatorcontrib><creatorcontrib>CURTIS, J. Randall</creatorcontrib><title>Narcotic and benzodiazepine use after withdrawal of life support: Association with time to death?</title><title>Chest</title><addtitle>Chest</addtitle><description>To determine whether the dose of narcotics and benzodiazepines is associated with length of time from mechanical ventilation withdrawal to death in the setting of withdrawal of life-sustaining treatment in the ICU.
Retrospective chart review.
University-affiliated, level I trauma center.
Consecutive critically ill patients who had mechanical ventilation withdrawn and subsequently died in the ICU during two study time periods.
There were 75 eligible patients with a mean age of 59 years. The primary ICU admission diagnoses included intracranial hemorrhage (37%), trauma (27%), acute respiratory failure (27%), and acute renal failure (20%). Patients died during a median of 35 min (range, 1 to 890 min) after ventilator withdrawal. On average, 16.2 mg/h opiates in morphine equivalents and 7.5 mg/h benzodiazepine in lorazepam equivalents were administered during the time period starting 1 h before ventilator withdrawal and ending at death. There was no statistically significant relationship between the average hourly narcotic and benzodiazepine use during the 1-h period prior to ventilator withdrawal until death, and the time from ventilator withdrawal to death. The restriction of medication assessment in the last 2 h of life showed an inverse association between the use of benzodiazepines and time to death. For every 1 mg/h increase in benzodiazepine use, time to death was increased by 13 min (p = 0.015). There was no relationship between narcotic dose and time to death during the last 2 h of life (p = 0.11).
We found no evidence that the use of narcotics or benzodiazepines to treat discomfort after the withdrawal of life support hastens death in critically ill patients at our center. Clinicians should strive to control patient symptoms in this setting and should document the rationale for escalating drug doses.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Anesthesia</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>APACHE</subject><subject>Benzodiazepines</subject><subject>Benzodiazepines - administration & dosage</subject><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Critical care</subject><subject>Ethics, Medical</subject><subject>Euthanasia, Passive - ethics</subject><subject>Female</subject><subject>Fentanyl</subject><subject>Glasgow Coma Scale</subject><subject>Humans</subject><subject>Intensive Care Units</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Morphine</subject><subject>Narcotics</subject><subject>Narcotics - administration & dosage</subject><subject>Nurses</subject><subject>Palliative care</subject><subject>Physicians</subject><subject>Pneumology</subject><subject>Quality improvement</subject><subject>Respiration, Artificial</subject><subject>Retrospective Studies</subject><subject>Time Factors</subject><subject>Ventilators</subject><issn>0012-3692</issn><issn>1931-3543</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpd0E1LxDAQBuAgiq6rP0EJgqKHar7abryILH6B6EE9l2mSYqRtapKyuL_eoKuIp2HgYXjnRWiPklNKaHH2RAhlGS8kO6b5CWeS5RldQxMqOc14Lvg6mvySLbQdwhtJO5XFJtqiORNSlHyC4AG8ctEqDL3GtemXTltYmsH2Bo_BYGii8Xhh46v2sIAWuwa3tjE4jMPgfDzHlyE4ZSFa1385HG1ncHRYG4ivFztoo4E2mN3VnKKX66vn-W12_3hzN7-8z4aUKWay1qXmxSx9QlldciVBzQoxA6rrBmqutW5ySUoqVIpeC1XmJeW01DI9w2vBp-jo--7g3ftoQqw6G5RpW-iNG0NVFGWqI9kpOvgH39zo-5StYoQIRlhOE9pfobHujK4GbzvwH9VPcwkcrgAEBW3joVc2_HEyFzNG-CceiX1R</recordid><startdate>20040701</startdate><enddate>20040701</enddate><creator>CHAN, Jeannie D</creator><creator>TREECE, Patsy D</creator><creator>ENGELBERG, Ruth A</creator><creator>CROWLEY, Lauren</creator><creator>RUBENFELD, Gordon D</creator><creator>STEINBERG, Kenneth P</creator><creator>CURTIS, J. Randall</creator><general>American College of Chest Physicians</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20040701</creationdate><title>Narcotic and benzodiazepine use after withdrawal of life support: Association with time to death?</title><author>CHAN, Jeannie D ; TREECE, Patsy D ; ENGELBERG, Ruth A ; CROWLEY, Lauren ; RUBENFELD, Gordon D ; STEINBERG, Kenneth P ; CURTIS, J. Randall</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p196t-9bd7d36832912b73c9ac8648a1dbfab3dddf590714c494b4c7571317d91523b43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Anesthesia</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>APACHE</topic><topic>Benzodiazepines</topic><topic>Benzodiazepines - administration & dosage</topic><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Critical care</topic><topic>Ethics, Medical</topic><topic>Euthanasia, Passive - ethics</topic><topic>Female</topic><topic>Fentanyl</topic><topic>Glasgow Coma Scale</topic><topic>Humans</topic><topic>Intensive Care Units</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Morphine</topic><topic>Narcotics</topic><topic>Narcotics - administration & dosage</topic><topic>Nurses</topic><topic>Palliative care</topic><topic>Physicians</topic><topic>Pneumology</topic><topic>Quality improvement</topic><topic>Respiration, Artificial</topic><topic>Retrospective Studies</topic><topic>Time Factors</topic><topic>Ventilators</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CHAN, Jeannie D</creatorcontrib><creatorcontrib>TREECE, Patsy D</creatorcontrib><creatorcontrib>ENGELBERG, Ruth A</creatorcontrib><creatorcontrib>CROWLEY, Lauren</creatorcontrib><creatorcontrib>RUBENFELD, Gordon D</creatorcontrib><creatorcontrib>STEINBERG, Kenneth P</creatorcontrib><creatorcontrib>CURTIS, J. Randall</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Chest</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CHAN, Jeannie D</au><au>TREECE, Patsy D</au><au>ENGELBERG, Ruth A</au><au>CROWLEY, Lauren</au><au>RUBENFELD, Gordon D</au><au>STEINBERG, Kenneth P</au><au>CURTIS, J. Randall</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Narcotic and benzodiazepine use after withdrawal of life support: Association with time to death?</atitle><jtitle>Chest</jtitle><addtitle>Chest</addtitle><date>2004-07-01</date><risdate>2004</risdate><volume>126</volume><issue>1</issue><spage>286</spage><epage>293</epage><pages>286-293</pages><issn>0012-3692</issn><eissn>1931-3543</eissn><coden>CHETBF</coden><abstract>To determine whether the dose of narcotics and benzodiazepines is associated with length of time from mechanical ventilation withdrawal to death in the setting of withdrawal of life-sustaining treatment in the ICU.
Retrospective chart review.
University-affiliated, level I trauma center.
Consecutive critically ill patients who had mechanical ventilation withdrawn and subsequently died in the ICU during two study time periods.
There were 75 eligible patients with a mean age of 59 years. The primary ICU admission diagnoses included intracranial hemorrhage (37%), trauma (27%), acute respiratory failure (27%), and acute renal failure (20%). Patients died during a median of 35 min (range, 1 to 890 min) after ventilator withdrawal. On average, 16.2 mg/h opiates in morphine equivalents and 7.5 mg/h benzodiazepine in lorazepam equivalents were administered during the time period starting 1 h before ventilator withdrawal and ending at death. There was no statistically significant relationship between the average hourly narcotic and benzodiazepine use during the 1-h period prior to ventilator withdrawal until death, and the time from ventilator withdrawal to death. The restriction of medication assessment in the last 2 h of life showed an inverse association between the use of benzodiazepines and time to death. For every 1 mg/h increase in benzodiazepine use, time to death was increased by 13 min (p = 0.015). There was no relationship between narcotic dose and time to death during the last 2 h of life (p = 0.11).
We found no evidence that the use of narcotics or benzodiazepines to treat discomfort after the withdrawal of life support hastens death in critically ill patients at our center. Clinicians should strive to control patient symptoms in this setting and should document the rationale for escalating drug doses.</abstract><cop>Northbrook, IL</cop><pub>American College of Chest Physicians</pub><pmid>15249473</pmid><doi>10.1016/S0012-3692(15)32925-1</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0012-3692 |
ispartof | Chest, 2004-07, Vol.126 (1), p.286-293 |
issn | 0012-3692 1931-3543 |
language | eng |
recordid | cdi_proquest_miscellaneous_66701252 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Adolescent Adult Aged Anesthesia Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy APACHE Benzodiazepines Benzodiazepines - administration & dosage Biological and medical sciences Cardiology. Vascular system Critical care Ethics, Medical Euthanasia, Passive - ethics Female Fentanyl Glasgow Coma Scale Humans Intensive Care Units Male Medical sciences Middle Aged Morphine Narcotics Narcotics - administration & dosage Nurses Palliative care Physicians Pneumology Quality improvement Respiration, Artificial Retrospective Studies Time Factors Ventilators |
title | Narcotic and benzodiazepine use after withdrawal of life support: Association with time to death? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T02%3A11%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Narcotic%20and%20benzodiazepine%20use%20after%20withdrawal%20of%20life%20support:%20Association%20with%20time%20to%20death?&rft.jtitle=Chest&rft.au=CHAN,%20Jeannie%20D&rft.date=2004-07-01&rft.volume=126&rft.issue=1&rft.spage=286&rft.epage=293&rft.pages=286-293&rft.issn=0012-3692&rft.eissn=1931-3543&rft.coden=CHETBF&rft_id=info:doi/10.1016/S0012-3692(15)32925-1&rft_dat=%3Cproquest_pubme%3E66701252%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=200420251&rft_id=info:pmid/15249473&rfr_iscdi=true |